Bacteria that are subjected to ribosome inhibiting antibiotic drugs show an interesting behavior: although adding drugs slows down cell growth, it also paradoxically increases the cell's concentration of ribosomes. We combine a prior nonlinear model of the energy-biomass balance in undrugged E. coli cells (Maitra and Dill, PNAS 2015 ) with Michaelis-Menten binding of drugs that inactivate ribosomes. Predictions are in good agreement with experiments on ribosomal concentrations and synthesis rates vs. drug concentrations and growth rates. The model indicates that the cell overproduces ribosomes in order to maintain an essentially constant ratio of active ribosomes to nonribosomal proteins, a key controller of cell behavior. The model also shows that drugged cells tend to maintain patterns of energy influx rates (glucose → ATP) that are the same as when the cells are undrugged. And, it predicts that adding drugs to slow-growing cells leads to a maximum point in the rate of ribosome synthesis. This type of modeling can provide insights into cellular driving forces that are difficult to measure.
INTRODUCTION
Drugs, such as chloramphenicol, act to reduce bacterial cell growth rates by inhibiting bacterial ribosomes, thereby reducing the cell's production of proteins. What actions does the cell evoke to counter the drug? On the one hand, there is often a good understanding of how the drug binds at its ribosomal site [1] [2] [3] and it is sometimes known how that binding interferes with protein elongation [4] [5] [6] [7] . It is also sometimes known how drugs sensitize local networks to evoke adaptive responses [8] [9] [10] [11] . While in bound-form, Rin, the ribosomes are inactivated, and they do not translate proteins. P degrades with a rate constant γ. The cell grows exponentially with a specific growth rate of λ. * Electronic address: arijitmaitra1@gmail.com † Electronic address: dill@laufercenter.org condition the cell might be trying to preserve.
There are various approaches to cell-level modeling. One approach models the dynamics of the cell's networks of biochemical reactions [12] [13] [14] . Even in an organism as simple as a bacterium, there are very many interconnected web of reactions, making it complicated to model. Another approach has been Flux-Balance Analysis [15, 16] , which gives solutions by linearizing the forces around some given homeostasis point. Here, however, we are interested in how those homeostasis points themselves are shifted by the drug. Homeostasis is a fundamentally nonlinear phenomenon, describing the cell's return to a stable state after a perturbation. Like the Le Chatelier Principle in physics [17] , homeostasis describes a process resembling a marble rolling back to the bottom of a well after being pushed, like a well-bottom of an energy function. Here, we treat the nonlinearities and feedbacks that are needed to explore how the homeostasis balance is tipped by the drug. But to do this in a way that can give simple insights, we use a reduced ('minimalist') description of the bacterial cell [18] . We use this model to study the response of E coli to chloramphenicol.
Our goal here is a quantitative description of the energy-limited cell in the absence or presence of varying amounts of drug, in terms of the physico-chemical processes of the undrugged cell developed recently [18] . (By energy limited, we mean cells that are growth limited by a sugar source, such as glucose, rather than by amino acids, for example). Our minimal model expresses the dynamical concentrations and fluxes of three internal cell components -ribosomal protein, nonribosomal protein, and internal energy (lumped into a single category we call ATP), as a function of external sugar, such as glucose. We previously found that healthy E. coli under good growth conditions (speeds up to one duplication per hour) have achieved an evolutionary balance [18] . On the one hand, the cell invests energy and biomass in increasing its ribosome concentration because that increases the cell's growth speed. On the other hand, too much en-ergy and biomass devoted to producing ribosomes leads to starving the cell's ability to take in food and convert it to ATP. In the present paper, we ask how drugging the cell affects its balance of energy and biomass.
A MINIMAL MODEL OF E. COLI IN THE PRESENCE OF DRUGS
We model the energy-limited growth of E. coli using three rate equations: for energy (ATP concentration, A) and ribosomal (R act ) and nonribosomal protein concentrations (P) as functions of time t [18] :
where the fluxes are defined as:
Here, J a is the rate of glucose conversion for ATP generation, J p and J r are the respective rates of synthesis of NRPs and ribosomes. k r , k p and k a (G) are the respective rate constants for ribosomal biogenesis, protein translation and energy generation. The units of rates and rate constants are 'mM per hour' and 'per hour' respectively. Our work is not the first to model the biomass balance in bacteria; see [19] [20] [21] [22] [23] [24] [25] . What is new here, we believe, is the coupling between the biomass and energy balance; also see [26] . The functional forms in Eqs. (5), (6), (7) reflect wildtype regulatory mechanisms that coordinate the syntheses of ribosomal and non-ribosomal proteins, which are complex [27, 28] and depend on the cell's energy status. To capture these dependencies, we adopt the undrugged cell functions [18] :
See S.I. for values of biophysical constants and parameters. In addition, here we consider the effects of drug X as shown in Fig. 1 . X is an antibiotic drug that targets ribosomes. There is a broad class of natural and synthetic bacteriostatic antibiotics of this type, such as chloramphenicol, that target protein synthesis. The present model is intended as a general description of that class of drugs [3] . We assume X permeates passively from the extracellular medium into the cytosol through the cell membrane. We assume free drug concentrations outside and inside the cell are equal, a reasonable approximation for E. coli based on similar values of drug binding kinetics from invivo and invitro measurements, see Ref. [29, 30] . The binding of X to the ribosomes, which occurs with rate constant k +x , halts peptide-chain elongation, as represented by the following dynamics:
Here, x is the extracellular concentration of drugs. R in is the concentration of ribosomes that have been inactivated by binding to the drug, and R act , as noted above, is the intracellular concentration of active ribosomes. So, R act + R in is the total concentration of ribosomes in the cell. J x is the overall rate at which ribosomes become inactivated since (k +x · x · R act ) is the rate of binding to the drug and (k −x · R in ) is the rate of unbinding.
A key quantity in the present model is the fraction of ribosomes that are active α(x), for a given drug concentration x. We assume steady state, so we set dR in /dt = 0 in Eq. (13) . We also assume that the rate constant for drug-ribosome unbinding is much faster than dilution, k −x λ. So, we get:
For the equilibrium dissociation constant of chloramphenical, we use (k −x /k +x ) ≡ K d ∼ 3µM [29] . α = 1 represents the situation of no drug. Increasing drug concentration decreases α towards zero. The fraction of all proteins (by mass) that are active ribosomes is
And, the fraction of all proteins that are all ribosomes (active plus inactive) is:
The last equality in Eq. 18 expresses how the ribosomal content of the cell depends on its growth rate λ and other properties. Further, the rate of ribosome synthesis, J f r ≡ M r J r /ρ, in units of g of ribosomal protein per g of total protein per hour can be computed as (see S.I.): Under growth conditions in the absence of drugs, α = 1, and f p = f ∞ p [18] the rate of ribosome synthesis is given as, using Eq. (18) and Eq. (19):
(20)
THE DRUGGED CELL OVERPRODUCES TOTAL RIBOSOMES TO MAINTAIN SUFFICIENTLY MANY ACTIVE RIBOSOMES
Here we describe the model predictions. We solve ODEs (1)- (14) under steady-state conditions for different concentrations of glucose and antibiotic drug. Fig.  2(A) shows that the model predicts Monod-like behavior [31] of growth rate vs. glucose concentration under different drug concentrations. As expected, the model predicts that increasing drug leads to diminishing maximumgrowth rates. Fig. 3 shows that the model is consistent with experiments indicating how added drug stimulates total ribosome production even as it reduces the cell's growth rate [10, 33] . The black line in Fig. 3 shows that, for undrugged cells, ribosomes become upshifted relative to other protein biomass with increasing cellular growth rate. The red line (and data points) show that added drug does two things: increases the ribosomal fraction while simultaneously reducing the growth rate.
What is the cell 'trying to achieve' under the burden of the drug? Fig. 4 gives insights; it shows that the cell maintains an essentially constant mass ratio, R act /(R act + P ), of active ribosomes to useful proteins (all proteins except inactive ribosomes). This is the basic quantity that controls the growth of the undrugged cell. That is, the cell overproduces total ribosomes so as to achieve sufficient active ribosomes in light of the increasing numbers of inactive ribosomes that result from increasing drug. To our knowledge, this ratio has not been measured experimentally. 
THE DRUG SHIFTS THE PRODUCTION RATE OF RIBOSOMES. BUT, IT HAS LITTLE EFFECT ON ENERGY FLOW FROM GLUCOSE
TO ATP. Fig. 5 illuminates the point from the perspective of total production rates of ribosomes. Fig. 5 shows J f r = λ · φ tot (λ), the relation between rate production of total ribosomes and growth rate.
First, focus on the black line in Fig. 5 . According to the model, under no-drugs the ribosomal production rate should scale as the square of the growth rate, Fig. 5 shows a loglog plot. The black line shows the square-law prediction for undrugged cells. The data points shown in gray lay along this black line, indicating that the model predicts well the ribosomal production rates of undrugged cells growing at different speeds.
Next, focus on the red points in Fig. 5 . The datapoints, containing the circled numbers 2 -12 µM, show the effects of increasing amounts of drug at fixed nutrients. Following the red line toward the left, which describes increasing drug concentrations, shows how the drug reduces the growth rate while it also reduces the rate of total ribosome production. The experiments are from ref. [10] ; also see SI.
Finally, the blue line on Fig. 5 makes an interesting prediction, for which there are no experiments yet as far as we know. The blue line represents cell growth under low nutrients, 0 < λ 0.8 h −1 . The blue line has curvature. Adding small amounts of drug increases the total ribosome production rates; adding much more drug leads to reduced rates of ribosome production because of its bigger effect on reducing the cell's growth rate. Fig. 6 shows the prediction of λ a (1 − φ) , which is a measure of flux of energy flow from glucose to ATP, m a k a (G) · P . Fig. 6 shows that the drugged cell is maintaining this energy-flux correlation with growth rate at undrugged-cell levels, even at different levels of drug. As far as we know, there are no experiments that bear on this prediction. 
DISCUSSION
We have shown here that this simple model is consistent with measured ribosomal concentrations vs. growth rate and drug concentrations. We would welcome additional experiments. Current experiments on drugged and undrugged bacteria are run on different food sources and in different media. Deeper tests of our model could come from studies that fix the types of nutrient and media, and vary only the food concentrations. In addition, a key variable here is λ a , the cell's conversion efficiency of sugar to internal energy, such as ATP. It would be also valuable to have measurements of: glucose and oxygen uptake rates, ATP production rates (m a J a ), ATP concentrations, and ribosome production rates (J r ), key glycolytic, TCA cycle, and fermentation enzyme concentrations as a function of external glucose and antibiotic concentrations.
Somewhat different models are those of Elf et al [34] and Deris et al [35] , who consider bistabilities of cells resulting either from membrane properties or drug resistance. Other models focus on mechanisms of microscopic control of ribosome synthesis, such as the "stringent response", a negative feedback mechanism triggered when some of cell's excess usable energetic molecules are converted to unusable ppGpp as response to endogenous limitations of aminoacids [21, 28, 36] . Because of its simplicity, the present treatment could be extended to explore other factors that are of interest, such as cellular geometry (surface-volume considerations), multi-drug effects [37] , or drug-dependent cellular multistabilities that lead to antibiotic resistance and persistence [34, 35] .
CONCLUSIONS
Here, we model the balance of energy, ribosomes and nonribosomal proteins in E. coli cells in the presence of chloramphenicol, an antibiotic drug. We suppose that chloramphenicol binds to ribosomes and inactivates them, in a Michaelis-Menten fashion. We combine this binding-induced inactivation with a three-component dynamical model of E. coli's energy, ribosomal and nonribosomal protein biomass as a function of growth rates, previously validated against experiments on undrugged bacteria. The present model gives quantitative predictions for how the cell's growth rate decreases with drug, and how the total ribosomal fraction of protein increases with drug. The main value of the model is not so much in fitting data as in giving deeper mechanistic insights into what the bacterium is 'trying to achieve' under increasing drug perturbations. We find that while drugging the cell causes dramatically lowered concentrations of active ribosomes, it also stimulates more total ribosome production, in an apparent effort to maintain a constant value of the balance of active ribosome to nonribosomal protein, a key quantity the cell uses to toggle between growth and self-protection. 
